Rank | Gene Set | Z-score |
---|---|---|
1 | hemidesmosome assembly (GO:0031581) | 5.45948466 |
2 | desmosome organization (GO:0002934) | 4.89664160 |
3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.39193067 |
4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.33151100 |
5 | response to peptidoglycan (GO:0032494) | 4.21243518 |
6 | regulation of vitamin metabolic process (GO:0030656) | 3.69740031 |
7 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.60703456 |
8 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.43150693 |
9 | wound healing, spreading of epidermal cells (GO:0035313) | 3.38147783 |
10 | positive regulation of p38MAPK cascade (GO:1900745) | 3.33263166 |
11 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.30022990 |
12 | regulation of p38MAPK cascade (GO:1900744) | 3.28401241 |
13 | germinal center formation (GO:0002467) | 3.22183341 |
14 | cell-substrate junction assembly (GO:0007044) | 3.19938537 |
15 | low-density lipoprotein particle clearance (GO:0034383) | 3.17264437 |
16 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17158928 |
17 | plasma membrane repair (GO:0001778) | 3.15326744 |
18 | cell adhesion mediated by integrin (GO:0033627) | 3.04375986 |
19 | protein localization to endosome (GO:0036010) | 3.02149467 |
20 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.00250439 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.99426121 |
22 | response to muramyl dipeptide (GO:0032495) | 2.99329411 |
23 | immunoglobulin mediated immune response (GO:0016064) | 2.96459399 |
24 | negative regulation of interleukin-12 production (GO:0032695) | 2.96036446 |
25 | regulation of necrotic cell death (GO:0010939) | 2.94232065 |
26 | detection of other organism (GO:0098543) | 2.93867680 |
27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93547965 |
28 | lymph vessel development (GO:0001945) | 2.90348753 |
29 | mature B cell differentiation involved in immune response (GO:0002313) | 2.87936083 |
30 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.87901712 |
31 | angiotensin maturation (GO:0002003) | 2.87785785 |
32 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.87319146 |
33 | surfactant homeostasis (GO:0043129) | 2.86096542 |
34 | establishment of endothelial barrier (GO:0061028) | 2.81811057 |
35 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81315999 |
36 | regulation of cardioblast differentiation (GO:0051890) | 2.81058506 |
37 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.78340508 |
38 | detection of bacterium (GO:0016045) | 2.77867401 |
39 | neutrophil activation involved in immune response (GO:0002283) | 2.76990408 |
40 | apoptotic cell clearance (GO:0043277) | 2.76210413 |
41 | pinocytosis (GO:0006907) | 2.75087856 |
42 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.74839179 |
43 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.74752655 |
44 | blood vessel endothelial cell migration (GO:0043534) | 2.73276623 |
45 | embryonic process involved in female pregnancy (GO:0060136) | 2.72902789 |
46 | T-helper 1 type immune response (GO:0042088) | 2.72585007 |
47 | regulation of cellular extravasation (GO:0002691) | 2.70192378 |
48 | mannose metabolic process (GO:0006013) | 2.69206210 |
49 | atrioventricular valve morphogenesis (GO:0003181) | 2.69007500 |
50 | lymphangiogenesis (GO:0001946) | 2.68955038 |
51 | morphogenesis of an endothelium (GO:0003159) | 2.67483721 |
52 | endothelial tube morphogenesis (GO:0061154) | 2.67483721 |
53 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66457398 |
54 | growth hormone receptor signaling pathway (GO:0060396) | 2.65688050 |
55 | regulation of leukocyte degranulation (GO:0043300) | 2.65110545 |
56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61707504 |
57 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.61688154 |
58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59099170 |
59 | regulation of necroptotic process (GO:0060544) | 2.58162591 |
60 | regulation of mast cell degranulation (GO:0043304) | 2.57879090 |
61 | wound healing, spreading of cells (GO:0044319) | 2.57413509 |
62 | regulation of podosome assembly (GO:0071801) | 2.57319586 |
63 | peptide catabolic process (GO:0043171) | 2.56844934 |
64 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.56789964 |
65 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.55278008 |
66 | cyclooxygenase pathway (GO:0019371) | 2.54770857 |
67 | endothelial cell morphogenesis (GO:0001886) | 2.53223474 |
68 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.53117841 |
69 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.52572268 |
70 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.52357759 |
71 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.51977181 |
72 | glycosphingolipid catabolic process (GO:0046479) | 2.51812114 |
73 | definitive hemopoiesis (GO:0060216) | 2.50437171 |
74 | regulation of cholesterol storage (GO:0010885) | 2.50007039 |
75 | complement activation, classical pathway (GO:0006958) | 2.49949164 |
76 | response to protozoan (GO:0001562) | 2.48448081 |
77 | detection of external biotic stimulus (GO:0098581) | 2.48182583 |
78 | basement membrane organization (GO:0071711) | 2.47777097 |
79 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.47427913 |
80 | negative regulation of granulocyte differentiation (GO:0030853) | 2.47334536 |
81 | modulation by symbiont of host defense response (GO:0052031) | 2.47125903 |
82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47125903 |
83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47125903 |
84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47125903 |
85 | modulation by symbiont of host immune response (GO:0052553) | 2.47125903 |
86 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47125903 |
87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46542570 |
88 | negative regulation of cell fate specification (GO:0009996) | 2.46071901 |
89 | response to laminar fluid shear stress (GO:0034616) | 2.45505814 |
90 | skin morphogenesis (GO:0043589) | 2.44864886 |
91 | complement activation, alternative pathway (GO:0006957) | 2.44170648 |
92 | complement activation (GO:0006956) | 2.43719706 |
93 | epithelial cell-cell adhesion (GO:0090136) | 2.42352183 |
94 | axon extension involved in axon guidance (GO:0048846) | 2.40583360 |
95 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.40583360 |
96 | fibroblast migration (GO:0010761) | 2.40230712 |
97 | patterning of blood vessels (GO:0001569) | 2.39651265 |
98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38570994 |
99 | NIK/NF-kappaB signaling (GO:0038061) | 2.37687410 |
100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36742298 |
101 | regulation of gamma-delta T cell activation (GO:0046643) | 2.36031450 |
102 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.35564438 |
103 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.35486748 |
104 | detection of molecule of bacterial origin (GO:0032490) | 2.35233476 |
105 | endothelial cell chemotaxis (GO:0035767) | 2.35214556 |
106 | substrate-dependent cell migration (GO:0006929) | 2.34847569 |
107 | cellular extravasation (GO:0045123) | 2.34400885 |
108 | negative regulation of interleukin-8 production (GO:0032717) | 2.33321785 |
109 | glycolipid catabolic process (GO:0019377) | 2.33146179 |
110 | semaphorin-plexin signaling pathway (GO:0071526) | 2.32108175 |
111 | defense response to protozoan (GO:0042832) | 2.31990191 |
112 | regulation of cholesterol homeostasis (GO:2000188) | 2.31824278 |
113 | positive regulation of type 2 immune response (GO:0002830) | 2.31701017 |
114 | chemical homeostasis within a tissue (GO:0048875) | 2.31305938 |
115 | detection of biotic stimulus (GO:0009595) | 2.30352571 |
116 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.28654247 |
117 | endodermal cell differentiation (GO:0035987) | 2.28560104 |
118 | regulation of chemokine biosynthetic process (GO:0045073) | 2.28545756 |
119 | regulation of antigen processing and presentation (GO:0002577) | 2.27863187 |
120 | positive regulation of leukocyte degranulation (GO:0043302) | 2.27702869 |
121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.27033558 |
122 | interferon-gamma secretion (GO:0072643) | 2.26423364 |
123 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.26370002 |
124 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.26330496 |
125 | regulation of water loss via skin (GO:0033561) | 2.25190209 |
126 | macrophage activation (GO:0042116) | 2.25160153 |
127 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.24416125 |
128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.24367531 |
129 | acute-phase response (GO:0006953) | 2.23953766 |
130 | cellular response to growth hormone stimulus (GO:0071378) | 2.23795983 |
131 | oligosaccharide catabolic process (GO:0009313) | 2.23530541 |
132 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.22974860 |
133 | glomerular filtration (GO:0003094) | 2.22653111 |
134 | mesodermal cell differentiation (GO:0048333) | 2.21742961 |
135 | stress fiber assembly (GO:0043149) | 2.21379600 |
136 | positive regulation of macrophage cytokine production (GO:0060907) | 2.20555457 |
137 | negative regulation of vascular permeability (GO:0043116) | 2.20488412 |
138 | response to thyroid hormone (GO:0097066) | 2.19985660 |
139 | positive regulation of B cell differentiation (GO:0045579) | 2.19136062 |
140 | regulation of complement activation (GO:0030449) | 2.18219405 |
141 | regulation of type 2 immune response (GO:0002828) | 2.18026772 |
142 | regulation of macrophage chemotaxis (GO:0010758) | 2.18025635 |
143 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.16134093 |
144 | positive regulation of antigen processing and presentation (GO:0002579) | 2.15795702 |
145 | macrophage activation involved in immune response (GO:0002281) | 2.15685831 |
146 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.15179172 |
147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.13902764 |
148 | response to host (GO:0075136) | 2.13902764 |
149 | response to host defenses (GO:0052200) | 2.13902764 |
150 | regulation of vasculogenesis (GO:2001212) | 2.13859722 |
151 | sarcomere organization (GO:0045214) | 2.13750539 |
152 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.13657266 |
153 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.12442380 |
154 | positive regulation of vasculogenesis (GO:2001214) | 2.12204703 |
155 | renal filtration (GO:0097205) | 2.12173811 |
156 | regulation of protein activation cascade (GO:2000257) | 2.12167841 |
157 | blood vessel maturation (GO:0001955) | 2.11858422 |
158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.11856545 |
159 | positive regulation of phagocytosis (GO:0050766) | 2.11443714 |
160 | adherens junction assembly (GO:0034333) | 2.10491055 |
161 | cell communication involved in cardiac conduction (GO:0086065) | 2.10366767 |
162 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.10079119 |
163 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.09361595 |
164 | regulation of endothelial cell differentiation (GO:0045601) | 2.09098971 |
165 | endothelium development (GO:0003158) | 2.07139898 |
166 | coronary vasculature morphogenesis (GO:0060977) | 2.06747527 |
167 | heart trabecula formation (GO:0060347) | 2.05910174 |
168 | intestinal epithelial cell development (GO:0060576) | 2.05867306 |
169 | negative regulation of fatty acid transport (GO:2000192) | 2.04813834 |
170 | regulation of tight junction assembly (GO:2000810) | 2.04187768 |
171 | positive regulation of histone deacetylation (GO:0031065) | 2.03676299 |
172 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.02009034 |
173 | negative regulation of heart growth (GO:0061117) | 2.02009034 |
174 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.01082600 |
175 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.01082600 |
176 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.00848542 |
177 | cardiac myofibril assembly (GO:0055003) | 1.99631926 |
178 | regulation of integrin activation (GO:0033623) | 1.99143293 |
179 | lung vasculature development (GO:0060426) | 1.98754672 |
180 | lung lobe morphogenesis (GO:0060463) | 1.98643473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.69367540 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.38874014 |
3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.86023606 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69491285 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55802143 |
6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.44597291 |
7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39629258 |
8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.38781037 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36209300 |
10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30439298 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15153086 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11329104 |
13 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.10723148 |
14 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99456874 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98687026 |
16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.94885878 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92836348 |
18 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86162768 |
19 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.85681065 |
20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81652050 |
21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.79738401 |
22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79347156 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79266362 |
24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.78176526 |
25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76440863 |
26 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.72888464 |
27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72734009 |
28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71361013 |
29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70772039 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.62565170 |
31 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.60066821 |
32 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.60066821 |
33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59406911 |
34 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58262604 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55821356 |
36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54305071 |
37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51622540 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51406592 |
39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.51176793 |
40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51145445 |
41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48629707 |
42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47199473 |
43 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.45302863 |
44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43670664 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43533571 |
46 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41549117 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40899349 |
48 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39586207 |
49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38422309 |
50 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.37788889 |
51 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36506234 |
52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36506234 |
53 | MYC_22102868_ChIP-Seq_BL_Human | 1.35720162 |
54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35408383 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35398857 |
56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34216874 |
57 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.33990313 |
58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32909259 |
59 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31295900 |
60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29672388 |
61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29331938 |
62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29068002 |
63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28499024 |
64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28172514 |
65 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28160811 |
66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27449350 |
67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27231135 |
68 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27068666 |
69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26744670 |
70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26343464 |
71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24835592 |
72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24241810 |
73 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23734248 |
74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23139863 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22071924 |
76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20894482 |
77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19101398 |
78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18853697 |
79 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18522019 |
80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17889996 |
81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17571921 |
82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16471358 |
83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15880761 |
84 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14849743 |
85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14057536 |
86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13173307 |
87 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13061611 |
88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12985382 |
89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10899571 |
90 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10350483 |
91 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09195402 |
92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09006205 |
93 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08125453 |
94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07857652 |
95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07459765 |
96 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06589279 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06482761 |
98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05651913 |
99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05542693 |
100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04019241 |
101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03684248 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03446337 |
103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03397542 |
104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03234651 |
105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02006591 |
106 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01508335 |
107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00847311 |
108 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00556245 |
109 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00534148 |
110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00332360 |
111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99348176 |
112 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99245449 |
113 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98622410 |
114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97956652 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97659271 |
116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97273585 |
117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96387704 |
118 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.96358446 |
119 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95634184 |
120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95572205 |
121 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94899848 |
122 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94856760 |
123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94834194 |
124 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93940507 |
125 | MYB_26560356_Chip-Seq_TH2_Human | 0.93689302 |
126 | MAF_26560356_Chip-Seq_TH1_Human | 0.93469772 |
127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93410063 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 3.98304074 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.60373845 |
3 | MP0010368_abnormal_lymphatic_system | 3.08556339 |
4 | MP0005167_abnormal_blood-brain_barrier | 2.81008368 |
5 | MP0004272_abnormal_basement_membrane | 2.67838225 |
6 | MP0002254_reproductive_system_inflammat | 2.63483509 |
7 | MP0003300_gastrointestinal_ulcer | 2.59831433 |
8 | MP0001879_abnormal_lymphatic_vessel | 2.52549989 |
9 | MP0002139_abnormal_hepatobiliary_system | 2.47502292 |
10 | MP0003566_abnormal_cell_adhesion | 2.40549505 |
11 | MP0003303_peritoneal_inflammation | 2.38602159 |
12 | MP0003828_pulmonary_edema | 2.24814943 |
13 | MP0002796_impaired_skin_barrier | 2.22368176 |
14 | MP0003724_increased_susceptibility_to | 2.21532555 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.18660649 |
16 | MP0010352_gastrointestinal_tract_polyps | 2.11022242 |
17 | MP0005275_abnormal_skin_tensile | 2.10427834 |
18 | MP0006054_spinal_hemorrhage | 2.09853039 |
19 | MP0001835_abnormal_antigen_presentation | 2.08084554 |
20 | MP0004947_skin_inflammation | 2.06124740 |
21 | MP0009278_abnormal_bone_marrow | 2.02739310 |
22 | MP0003453_abnormal_keratinocyte_physiol | 2.02338482 |
23 | MP0004510_myositis | 1.98017496 |
24 | MP0005025_abnormal_response_to | 1.95135933 |
25 | MP0005058_abnormal_lysosome_morphology | 1.94332013 |
26 | MP0005451_abnormal_body_composition | 1.92433097 |
27 | MP0005464_abnormal_platelet_physiology | 1.86152395 |
28 | MP0005076_abnormal_cell_differentiation | 1.83932274 |
29 | MP0005360_urolithiasis | 1.83040363 |
30 | MP0000465_gastrointestinal_hemorrhage | 1.79921385 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.79459502 |
32 | MP0001545_abnormal_hematopoietic_system | 1.79459502 |
33 | MP0005000_abnormal_immune_tolerance | 1.78881191 |
34 | MP0005387_immune_system_phenotype | 1.69811308 |
35 | MP0001790_abnormal_immune_system | 1.69811308 |
36 | MP0004264_abnormal_extraembryonic_tissu | 1.69288844 |
37 | MP0006082_CNS_inflammation | 1.65339525 |
38 | MP0002060_abnormal_skin_morphology | 1.65072467 |
39 | MP0002877_abnormal_melanocyte_morpholog | 1.62618457 |
40 | MP0004084_abnormal_cardiac_muscle | 1.61099432 |
41 | MP0005023_abnormal_wound_healing | 1.54059773 |
42 | MP0001849_ear_inflammation | 1.52862359 |
43 | MP0002452_abnormal_antigen_presenting | 1.47035441 |
44 | MP0005409_darkened_coat_color | 1.46675809 |
45 | MP0001800_abnormal_humoral_immune | 1.45359001 |
46 | MP0002396_abnormal_hematopoietic_system | 1.45260479 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.44189838 |
48 | MP0001216_abnormal_epidermal_layer | 1.44017527 |
49 | MP0002723_abnormal_immune_serum | 1.42878867 |
50 | MP0002138_abnormal_hepatobiliary_system | 1.40612257 |
51 | MP0001853_heart_inflammation | 1.38595190 |
52 | * MP0010678_abnormal_skin_adnexa | 1.36911107 |
53 | MP0000604_amyloidosis | 1.33100137 |
54 | MP0003436_decreased_susceptibility_to | 1.33004728 |
55 | MP0001845_abnormal_inflammatory_respons | 1.31468333 |
56 | MP0000750_abnormal_muscle_regeneration | 1.30331024 |
57 | MP0008961_abnormal_basal_metabolism | 1.29289242 |
58 | MP0001819_abnormal_immune_cell | 1.27289377 |
59 | MP0000767_abnormal_smooth_muscle | 1.26754711 |
60 | MP0002420_abnormal_adaptive_immunity | 1.26671129 |
61 | MP0003045_fibrosis | 1.25891576 |
62 | MP0003656_abnormal_erythrocyte_physiolo | 1.25033974 |
63 | MP0008469_abnormal_protein_level | 1.24362489 |
64 | MP0003091_abnormal_cell_migration | 1.22188188 |
65 | MP0000685_abnormal_immune_system | 1.22043021 |
66 | MP0004808_abnormal_hematopoietic_stem | 1.21549326 |
67 | MP0000343_altered_response_to | 1.21014576 |
68 | MP0000858_altered_metastatic_potential | 1.20604907 |
69 | MP0002166_altered_tumor_susceptibility | 1.18956067 |
70 | MP0005165_increased_susceptibility_to | 1.18467937 |
71 | MP0003866_abnormal_defecation | 1.17268887 |
72 | MP0003172_abnormal_lysosome_physiology | 1.17243736 |
73 | MP0002405_respiratory_system_inflammati | 1.17117660 |
74 | MP0010630_abnormal_cardiac_muscle | 1.16643389 |
75 | MP0010155_abnormal_intestine_physiology | 1.14183580 |
76 | MP0004130_abnormal_muscle_cell | 1.13769867 |
77 | MP0008004_abnormal_stomach_pH | 1.11955342 |
78 | MP0009333_abnormal_splenocyte_physiolog | 1.11844087 |
79 | MP0005501_abnormal_skin_physiology | 1.10216790 |
80 | MP0000013_abnormal_adipose_tissue | 1.10146813 |
81 | * MP0000383_abnormal_hair_follicle | 1.09550923 |
82 | MP0004484_altered_response_of | 1.09344323 |
83 | MP0001851_eye_inflammation | 1.09318721 |
84 | MP0001544_abnormal_cardiovascular_syste | 1.09305112 |
85 | MP0005385_cardiovascular_system_phenoty | 1.09305112 |
86 | MP0003075_altered_response_to | 1.09145533 |
87 | MP0003183_abnormal_peptide_metabolism | 1.08433524 |
88 | MP0002972_abnormal_cardiac_muscle | 1.08325324 |
89 | MP0005666_abnormal_adipose_tissue | 1.06863875 |
90 | MP0001533_abnormal_skeleton_physiology | 1.06837505 |
91 | MP0005330_cardiomyopathy | 1.06342884 |
92 | MP0008438_abnormal_cutaneous_collagen | 1.05769700 |
93 | MP0000537_abnormal_urethra_morphology | 1.05045135 |
94 | MP0004185_abnormal_adipocyte_glucose | 1.04731622 |
95 | MP0009785_altered_susceptibility_to | 1.04143853 |
96 | MP0001958_emphysema | 1.03871181 |
97 | MP0006138_congestive_heart_failure | 1.03502196 |
98 | MP0003329_amyloid_beta_deposits | 1.02961658 |
99 | MP0000751_myopathy | 1.02954121 |
100 | MP0004087_abnormal_muscle_fiber | 1.02801261 |
101 | MP0000678_abnormal_parathyroid_gland | 1.02725221 |
102 | MP0002006_tumorigenesis | 1.00263381 |
103 | MP0002998_abnormal_bone_remodeling | 0.99055178 |
104 | MP0005365_abnormal_bile_salt | 0.98526484 |
105 | MP0002896_abnormal_bone_mineralization | 0.97796010 |
106 | MP0004215_abnormal_myocardial_fiber | 0.95517804 |
107 | MP0005187_abnormal_penis_morphology | 0.95222156 |
108 | MP0000249_abnormal_blood_vessel | 0.94824064 |
109 | * MP0002098_abnormal_vibrissa_morphology | 0.94752580 |
110 | MP0001666_abnormal_nutrient_absorption | 0.94195129 |
111 | MP0002837_dystrophic_cardiac_calcinosis | 0.93511407 |
112 | MP0000716_abnormal_immune_system | 0.92842307 |
113 | MP0001191_abnormal_skin_condition | 0.91542753 |
114 | MP0003279_aneurysm | 0.90710255 |
115 | MP0000733_abnormal_muscle_development | 0.90168339 |
116 | MP0003763_abnormal_thymus_physiology | 0.89979626 |
117 | MP0004782_abnormal_surfactant_physiolog | 0.89355846 |
118 | MP0005390_skeleton_phenotype | 0.89057228 |
119 | MP0003806_abnormal_nucleotide_metabolis | 0.88929608 |
120 | MP0009931_abnormal_skin_appearance | 0.86967519 |
121 | MP0009763_increased_sensitivity_to | 0.86540057 |
122 | MP0000003_abnormal_adipose_tissue | 0.86200158 |
123 | MP0008775_abnormal_heart_ventricle | 0.85797986 |
124 | * MP0010771_integument_phenotype | 0.84436342 |
125 | MP0002398_abnormal_bone_marrow | 0.83292216 |
126 | * MP0002925_abnormal_cardiovascular_devel | 0.83027321 |
127 | MP0005164_abnormal_response_to | 0.82451072 |
128 | MP0004036_abnormal_muscle_relaxation | 0.82365143 |
129 | MP0005166_decreased_susceptibility_to | 0.81642655 |
130 | MP0009780_abnormal_chondrocyte_physiolo | 0.81596029 |
131 | MP0005085_abnormal_gallbladder_physiolo | 0.81275389 |
132 | MP0000377_abnormal_hair_follicle | 0.81100267 |
133 | MP0002234_abnormal_pharynx_morphology | 0.80936522 |
134 | MP0005375_adipose_tissue_phenotype | 0.80934538 |
135 | MP0001243_abnormal_dermal_layer | 0.80618930 |
136 | MP0003690_abnormal_glial_cell | 0.80358445 |
137 | MP0009840_abnormal_foam_cell | 0.80180707 |
138 | MP0003941_abnormal_skin_development | 0.80088413 |
139 | MP0002295_abnormal_pulmonary_circulatio | 0.79507320 |
140 | MP0000579_abnormal_nail_morphology | 0.79429089 |
141 | MP0002332_abnormal_exercise_endurance | 0.79161992 |
142 | MP0005671_abnormal_response_to | 0.78088010 |
143 | MP0009643_abnormal_urine_homeostasis | 0.76968283 |
144 | MP0009765_abnormal_xenobiotic_induced | 0.76778994 |
145 | MP0002128_abnormal_blood_circulation | 0.75762063 |
146 | MP0009764_decreased_sensitivity_to | 0.74501227 |
147 | MP0002419_abnormal_innate_immunity | 0.73575145 |
148 | MP0009053_abnormal_anal_canal | 0.71738662 |
149 | MP0000467_abnormal_esophagus_morphology | 0.70912344 |
150 | * MP0003448_altered_tumor_morphology | 0.70254956 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 5.30880886 |
2 | Systemic lupus erythematosus (HP:0002725) | 4.65142868 |
3 | Milia (HP:0001056) | 4.32293745 |
4 | Atrophic scars (HP:0001075) | 3.92485432 |
5 | Hematochezia (HP:0002573) | 3.66961869 |
6 | Complement deficiency (HP:0004431) | 3.63915787 |
7 | Increased connective tissue (HP:0009025) | 3.46569274 |
8 | Abnormality of complement system (HP:0005339) | 3.46487360 |
9 | Ventricular tachycardia (HP:0004756) | 3.44579274 |
10 | Cerebral aneurysm (HP:0004944) | 3.31826041 |
11 | Malnutrition (HP:0004395) | 3.19921051 |
12 | Glomerulonephritis (HP:0000099) | 3.15045109 |
13 | Onycholysis (HP:0001806) | 3.09163097 |
14 | Plantar hyperkeratosis (HP:0007556) | 3.07462324 |
15 | Esophageal varix (HP:0002040) | 3.07400268 |
16 | Amyloidosis (HP:0011034) | 3.05721091 |
17 | Myositis (HP:0100614) | 3.04710839 |
18 | Orchitis (HP:0100796) | 2.96571699 |
19 | Fragile nails (HP:0001808) | 2.90337856 |
20 | Sudden death (HP:0001699) | 2.86739409 |
21 | Polycythemia (HP:0001901) | 2.85164641 |
22 | Thick nail (HP:0001805) | 2.83688916 |
23 | Abnormality of macrophages (HP:0004311) | 2.82703994 |
24 | Hyporeflexia of lower limbs (HP:0002600) | 2.81268290 |
25 | Deep venous thrombosis (HP:0002625) | 2.78852418 |
26 | Rectal prolapse (HP:0002035) | 2.76788660 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73195205 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73195205 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73195205 |
30 | Increased cerebral lipofuscin (HP:0011813) | 2.67067251 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61931003 |
32 | Interstitial pulmonary disease (HP:0006530) | 2.61010187 |
33 | Cellulitis (HP:0100658) | 2.59488200 |
34 | Recurrent abscess formation (HP:0002722) | 2.57841073 |
35 | Recurrent bacterial skin infections (HP:0005406) | 2.57283660 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56843121 |
37 | Woolly hair (HP:0002224) | 2.51538877 |
38 | Polygenic inheritance (HP:0010982) | 2.51500076 |
39 | Gingival bleeding (HP:0000225) | 2.49808713 |
40 | Alopecia of scalp (HP:0002293) | 2.48553953 |
41 | Prolonged bleeding time (HP:0003010) | 2.44594363 |
42 | Epistaxis (HP:0000421) | 2.42611892 |
43 | Purpura (HP:0000979) | 2.40590037 |
44 | Eczematoid dermatitis (HP:0000976) | 2.39473297 |
45 | Retrobulbar optic neuritis (HP:0100654) | 2.39390307 |
46 | Optic neuritis (HP:0100653) | 2.39390307 |
47 | Spontaneous hematomas (HP:0007420) | 2.38380549 |
48 | Aortic aneurysm (HP:0004942) | 2.37347135 |
49 | Gingivitis (HP:0000230) | 2.37114580 |
50 | Aneurysm (HP:0002617) | 2.35978936 |
51 | Fragile skin (HP:0001030) | 2.35846604 |
52 | Ventricular fibrillation (HP:0001663) | 2.32761190 |
53 | Muscle fiber splitting (HP:0003555) | 2.32509395 |
54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31783933 |
55 | Neurofibrillary tangles (HP:0002185) | 2.27664076 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27623558 |
57 | Arterial tortuosity (HP:0005116) | 2.26707078 |
58 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.26532892 |
59 | Hypotrichosis (HP:0001006) | 2.26345930 |
60 | Colitis (HP:0002583) | 2.26258546 |
61 | Dysostosis multiplex (HP:0000943) | 2.24718234 |
62 | Mitral valve prolapse (HP:0001634) | 2.23519568 |
63 | Mediastinal lymphadenopathy (HP:0100721) | 2.22844151 |
64 | Broad metatarsal (HP:0001783) | 2.21935105 |
65 | Syncope (HP:0001279) | 2.19866674 |
66 | Protrusio acetabuli (HP:0003179) | 2.19480534 |
67 | Pili torti (HP:0003777) | 2.19055198 |
68 | Subacute progressive viral hepatitis (HP:0006572) | 2.18943182 |
69 | Keratoconjunctivitis sicca (HP:0001097) | 2.18648358 |
70 | Palmoplantar hyperkeratosis (HP:0000972) | 2.17556566 |
71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16829384 |
72 | Difficulty climbing stairs (HP:0003551) | 2.15732422 |
73 | Myocardial infarction (HP:0001658) | 2.15035065 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.13961113 |
75 | Increased serum ferritin (HP:0003281) | 2.12594166 |
76 | Abnormality of the gastric mucosa (HP:0004295) | 2.11867180 |
77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10173843 |
78 | Stomatitis (HP:0010280) | 2.10014720 |
79 | Vasculitis (HP:0002633) | 2.03924421 |
80 | Loss of speech (HP:0002371) | 2.02764488 |
81 | Micronodular cirrhosis (HP:0001413) | 2.02419450 |
82 | Vascular tortuosity (HP:0004948) | 2.01278218 |
83 | Pustule (HP:0200039) | 2.00458237 |
84 | Peritonitis (HP:0002586) | 2.00387746 |
85 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99728584 |
86 | Exercise-induced muscle cramps (HP:0003710) | 1.99570221 |
87 | Difficulty running (HP:0009046) | 1.99178814 |
88 | Gangrene (HP:0100758) | 1.99071199 |
89 | Lymphangioma (HP:0100764) | 1.97827672 |
90 | Petechiae (HP:0000967) | 1.97779669 |
91 | Recurrent viral infections (HP:0004429) | 1.97717355 |
92 | Abnormality of iron homeostasis (HP:0011031) | 1.97481636 |
93 | Palmar hyperkeratosis (HP:0010765) | 1.96238360 |
94 | Inflammation of the large intestine (HP:0002037) | 1.95100295 |
95 | Nail dystrophy (HP:0008404) | 1.93647468 |
96 | Aortic dissection (HP:0002647) | 1.93473406 |
97 | Flat acetabular roof (HP:0003180) | 1.92720418 |
98 | Shallow orbits (HP:0000586) | 1.92148310 |
99 | Hypoplasia of dental enamel (HP:0006297) | 1.91103274 |
100 | Gastrointestinal inflammation (HP:0004386) | 1.90259148 |
101 | Recurrent skin infections (HP:0001581) | 1.89080216 |
102 | Ventricular arrhythmia (HP:0004308) | 1.89020792 |
103 | Xerostomia (HP:0000217) | 1.88498509 |
104 | Axonal loss (HP:0003447) | 1.88417328 |
105 | Asymmetric septal hypertrophy (HP:0001670) | 1.88086786 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 1.87996822 |
107 | Mucopolysacchariduria (HP:0008155) | 1.86961453 |
108 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86961453 |
109 | Recurrent fungal infections (HP:0002841) | 1.86802893 |
110 | Urticaria (HP:0001025) | 1.85755998 |
111 | Arterial thrombosis (HP:0004420) | 1.85396146 |
112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85072640 |
113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85072640 |
114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85072640 |
115 | Osteolytic defects of the hand bones (HP:0009699) | 1.84574117 |
116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84574117 |
117 | Ankyloglossia (HP:0010296) | 1.83768251 |
118 | Long toe (HP:0010511) | 1.83528654 |
119 | Keratoconjunctivitis (HP:0001096) | 1.82900814 |
120 | Meningitis (HP:0001287) | 1.82781362 |
121 | Atrial fibrillation (HP:0005110) | 1.81543502 |
122 | Type 1 muscle fiber predominance (HP:0003803) | 1.81517355 |
123 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.81178195 |
124 | Neonatal death (HP:0003811) | 1.80851803 |
125 | Striae distensae (HP:0001065) | 1.80752378 |
126 | Hypergammaglobulinemia (HP:0010702) | 1.79496596 |
127 | Distal lower limb muscle weakness (HP:0009053) | 1.77534060 |
128 | Thrombocytosis (HP:0001894) | 1.77478714 |
129 | Spinal rigidity (HP:0003306) | 1.77341055 |
130 | Impaired platelet aggregation (HP:0003540) | 1.76592721 |
131 | Abnormal platelet function (HP:0011869) | 1.76592721 |
132 | Stroke (HP:0001297) | 1.76426460 |
133 | Obstructive lung disease (HP:0006536) | 1.76050276 |
134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76050276 |
135 | Dilatation of the ascending aorta (HP:0005111) | 1.75875912 |
136 | Tetraparesis (HP:0002273) | 1.74616052 |
137 | Pulmonary infiltrates (HP:0002113) | 1.74516109 |
138 | Thin bony cortex (HP:0002753) | 1.73015956 |
139 | Curly hair (HP:0002212) | 1.72839822 |
140 | Nephritis (HP:0000123) | 1.72685049 |
141 | Cerebral inclusion bodies (HP:0100314) | 1.72213760 |
142 | Acanthosis nigricans (HP:0000956) | 1.71492722 |
143 | Primary atrial arrhythmia (HP:0001692) | 1.70968094 |
144 | Supraventricular arrhythmia (HP:0005115) | 1.70528428 |
145 | Scapular winging (HP:0003691) | 1.70448232 |
146 | Episodic fever (HP:0001954) | 1.68752766 |
147 | Lipoatrophy (HP:0100578) | 1.68501241 |
148 | Cervical subluxation (HP:0003308) | 1.68454009 |
149 | Abnormality of the nasal mucosa (HP:0000433) | 1.67685352 |
150 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67418185 |
151 | Visceral angiomatosis (HP:0100761) | 1.67360129 |
152 | Hemoptysis (HP:0002105) | 1.66560517 |
153 | Premature rupture of membranes (HP:0001788) | 1.66099350 |
154 | Thrombophlebitis (HP:0004418) | 1.65987533 |
155 | Erythema (HP:0010783) | 1.65548008 |
156 | Pulmonary embolism (HP:0002204) | 1.65261341 |
157 | Joint swelling (HP:0001386) | 1.65255588 |
158 | Chest pain (HP:0100749) | 1.64221191 |
159 | Periodontitis (HP:0000704) | 1.64153600 |
160 | Hemorrhage of the eye (HP:0011885) | 1.63632342 |
161 | EMG: myopathic abnormalities (HP:0003458) | 1.63455668 |
162 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63384690 |
163 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62013370 |
164 | Mesangial abnormality (HP:0001966) | 1.61528932 |
165 | Distal lower limb amyotrophy (HP:0008944) | 1.60864490 |
166 | Abnormal blistering of the skin (HP:0008066) | 1.60375811 |
167 | Increased IgE level (HP:0003212) | 1.58426482 |
168 | Aplasia cutis congenita (HP:0001057) | 1.58327845 |
169 | Supraventricular tachycardia (HP:0004755) | 1.57985304 |
170 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.57197735 |
171 | Bundle branch block (HP:0011710) | 1.56920645 |
172 | Ankle contracture (HP:0006466) | 1.55924859 |
173 | Hemangiomatosis (HP:0007461) | 1.54904439 |
174 | Bicuspid aortic valve (HP:0001647) | 1.53457180 |
175 | Palpitations (HP:0001962) | 1.51301741 |
176 | Lip pit (HP:0100267) | 1.51280169 |
177 | Advanced eruption of teeth (HP:0006288) | 1.50555871 |
178 | Abnormality of oral frenula (HP:0000190) | 1.50242304 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 3.37740497 |
2 | TIE1 | 3.30017664 |
3 | PRPF4B | 3.15664512 |
4 | ERN1 | 3.08048308 |
5 | RIPK1 | 3.06991579 |
6 | TRIB3 | 3.04979145 |
7 | TGFBR2 | 2.64377586 |
8 | EPHA2 | 2.61714553 |
9 | KDR | 2.60569605 |
10 | PKN2 | 2.57307391 |
11 | TTN | 2.31442027 |
12 | PTK6 | 2.26005338 |
13 | MAP3K3 | 2.05665107 |
14 | MAP3K10 | 1.96516608 |
15 | MST4 | 1.95265760 |
16 | DMPK | 1.91435494 |
17 | MST1R | 1.89287508 |
18 | FER | 1.87211231 |
19 | EPHB1 | 1.83007736 |
20 | KIT | 1.70003240 |
21 | STK10 | 1.65811647 |
22 | BLK | 1.61657322 |
23 | LRRK2 | 1.57916285 |
24 | MAP2K2 | 1.55259004 |
25 | LATS1 | 1.52556400 |
26 | TAOK2 | 1.52210686 |
27 | MATK | 1.49198229 |
28 | PDGFRA | 1.46162924 |
29 | MAP3K2 | 1.44934545 |
30 | FGFR4 | 1.40166280 |
31 | EPHB2 | 1.39364945 |
32 | TBK1 | 1.37009852 |
33 | CDC42BPA | 1.35901895 |
34 | PTK2 | 1.31528056 |
35 | LMTK2 | 1.30365531 |
36 | MAP2K3 | 1.29341129 |
37 | PRKG2 | 1.25115582 |
38 | IRAK1 | 1.23925026 |
39 | BMPR2 | 1.23039547 |
40 | IRAK4 | 1.22436760 |
41 | PDGFRB | 1.20073467 |
42 | FES | 1.19896097 |
43 | MAP3K14 | 1.19885040 |
44 | SCYL2 | 1.17898033 |
45 | LATS2 | 1.12349087 |
46 | FGFR3 | 1.11528099 |
47 | NME2 | 1.10813865 |
48 | GRK7 | 1.08833272 |
49 | TAOK1 | 1.07341499 |
50 | FRK | 1.05419909 |
51 | MAP3K7 | 1.05377496 |
52 | TYK2 | 1.05046554 |
53 | MAPKAPK3 | 1.04984117 |
54 | MAP3K6 | 1.04577225 |
55 | KSR2 | 1.02812366 |
56 | CSK | 1.01324195 |
57 | MAPK15 | 1.01161401 |
58 | FLT3 | 1.00346292 |
59 | BMX | 0.97400794 |
60 | EPHA3 | 0.97158369 |
61 | CSF1R | 0.96749006 |
62 | JAK1 | 0.94161716 |
63 | IRAK2 | 0.93012847 |
64 | MAP3K11 | 0.92708243 |
65 | PAK4 | 0.92570248 |
66 | SIK1 | 0.92285556 |
67 | CHUK | 0.89600440 |
68 | TGFBR1 | 0.89363121 |
69 | MET | 0.88149299 |
70 | MAP2K1 | 0.86250855 |
71 | PIM2 | 0.85693468 |
72 | TAOK3 | 0.85305631 |
73 | PDK2 | 0.84660524 |
74 | RPS6KA4 | 0.83905955 |
75 | PTK2B | 0.79965213 |
76 | TRPM7 | 0.77711112 |
77 | SYK | 0.77599879 |
78 | PRKD1 | 0.77388732 |
79 | JAK2 | 0.76568143 |
80 | DDR2 | 0.75794658 |
81 | ZAP70 | 0.75340552 |
82 | MARK2 | 0.75032538 |
83 | RET | 0.73422931 |
84 | RIPK4 | 0.71978048 |
85 | * MAP3K1 | 0.71309204 |
86 | GRK6 | 0.71272317 |
87 | ABL2 | 0.71138453 |
88 | BTK | 0.70218076 |
89 | SMG1 | 0.67885510 |
90 | HIPK2 | 0.67404543 |
91 | FGR | 0.64062476 |
92 | CDK12 | 0.63003061 |
93 | RPS6KC1 | 0.62234842 |
94 | RPS6KL1 | 0.62234842 |
95 | JAK3 | 0.59701584 |
96 | MAP4K1 | 0.59488853 |
97 | MAP2K6 | 0.59365324 |
98 | NEK9 | 0.59029751 |
99 | CDK6 | 0.57985819 |
100 | IKBKE | 0.56372685 |
101 | PRKCH | 0.55218425 |
102 | FGFR1 | 0.55030838 |
103 | PDK1 | 0.54741685 |
104 | EGFR | 0.54494314 |
105 | ALK | 0.54397263 |
106 | DAPK2 | 0.53205311 |
107 | HCK | 0.52988932 |
108 | RPS6KA2 | 0.52769698 |
109 | RPS6KB2 | 0.51703578 |
110 | STK24 | 0.51451087 |
111 | PAK2 | 0.49968224 |
112 | MAPK11 | 0.49896016 |
113 | LYN | 0.48819425 |
114 | LCK | 0.48700851 |
115 | GSK3A | 0.48131812 |
116 | ICK | 0.48050567 |
117 | MAPK4 | 0.47390647 |
118 | MTOR | 0.46880511 |
119 | PDPK1 | 0.46276784 |
120 | CAMK1D | 0.46065007 |
121 | PAK3 | 0.45707202 |
122 | ACVR1B | 0.45042891 |
123 | RPS6KA6 | 0.44747151 |
124 | MYLK | 0.44142655 |
125 | ITK | 0.44056074 |
126 | EEF2K | 0.43541879 |
127 | ERBB2 | 0.43539024 |
128 | SRC | 0.43502476 |
129 | CAMKK1 | 0.40886505 |
130 | MAP3K13 | 0.40550939 |
131 | PRKAA2 | 0.40419836 |
132 | MAP3K9 | 0.38335289 |
133 | PIK3CA | 0.37845876 |
134 | ERBB3 | 0.37569757 |
135 | MAPKAPK2 | 0.37422298 |
136 | IKBKB | 0.37374799 |
137 | RPS6KA1 | 0.37324261 |
138 | MOS | 0.37307806 |
139 | MAP3K8 | 0.37245615 |
140 | INSR | 0.36129851 |
141 | STK3 | 0.35948283 |
142 | MAPK12 | 0.34886700 |
143 | MARK3 | 0.34611506 |
144 | MAPK7 | 0.33855752 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41529917 |
2 | Adherens junction_Homo sapiens_hsa04520 | 1.78654510 |
3 | Asthma_Homo sapiens_hsa05310 | 1.75956111 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75841478 |
5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74486847 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71696495 |
7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.69795819 |
8 | Amoebiasis_Homo sapiens_hsa05146 | 1.67277420 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66906419 |
10 | Focal adhesion_Homo sapiens_hsa04510 | 1.57902205 |
11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57173270 |
12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55680039 |
13 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.51986045 |
14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.51366181 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 1.51262396 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46867064 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44845989 |
18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.40955710 |
19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39724418 |
20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.30562287 |
21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27372827 |
22 | Malaria_Homo sapiens_hsa05144 | 1.25959708 |
23 | Insulin resistance_Homo sapiens_hsa04931 | 1.23580683 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21115572 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20597882 |
26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20055387 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19174939 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16550401 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.15909450 |
30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14801315 |
31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12637483 |
32 | Prion diseases_Homo sapiens_hsa05020 | 1.11824532 |
33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11761806 |
34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11450982 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09654717 |
36 | Bladder cancer_Homo sapiens_hsa05219 | 1.08481071 |
37 | Salmonella infection_Homo sapiens_hsa05132 | 1.07840000 |
38 | Legionellosis_Homo sapiens_hsa05134 | 1.07281655 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06129740 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05372477 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03881178 |
42 | Mineral absorption_Homo sapiens_hsa04978 | 1.02951996 |
43 | Platelet activation_Homo sapiens_hsa04611 | 0.99883932 |
44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99653093 |
45 | Tuberculosis_Homo sapiens_hsa05152 | 0.96421890 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95584580 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93914258 |
48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.93469725 |
49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92896147 |
50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90787001 |
51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90392880 |
52 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89393135 |
53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88586630 |
54 | Tight junction_Homo sapiens_hsa04530 | 0.87315680 |
55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87263745 |
56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86943851 |
57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86422885 |
58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85285143 |
59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84439863 |
60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84227516 |
61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83440252 |
62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83189438 |
63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83128119 |
64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82486544 |
65 | Hepatitis C_Homo sapiens_hsa05160 | 0.79717783 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79187643 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79013495 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77154337 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76949513 |
70 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76889848 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76236996 |
72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76111691 |
73 | Influenza A_Homo sapiens_hsa05164 | 0.75977988 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75638146 |
75 | Measles_Homo sapiens_hsa05162 | 0.74567731 |
76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72782235 |
77 | Apoptosis_Homo sapiens_hsa04210 | 0.72073941 |
78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72021404 |
79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71849500 |
80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71255200 |
81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70433903 |
82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69886717 |
83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69668340 |
84 | Bile secretion_Homo sapiens_hsa04976 | 0.69208112 |
85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68657112 |
86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68554391 |
87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68200917 |
88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67767262 |
89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66754316 |
90 | Shigellosis_Homo sapiens_hsa05131 | 0.66672474 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66541555 |
92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66390475 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66178779 |
94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65660482 |
95 | Renin secretion_Homo sapiens_hsa04924 | 0.65217596 |
96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64729072 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.62740945 |
98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62687980 |
99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61785130 |
100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61276408 |
101 | Hepatitis B_Homo sapiens_hsa05161 | 0.60584518 |
102 | Phagosome_Homo sapiens_hsa04145 | 0.60581364 |
103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60408351 |
104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59520154 |
105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59510485 |
106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59483335 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59148017 |
108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58934921 |
109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58903741 |
110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57083069 |
111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56634120 |
112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56449130 |
113 | Lysosome_Homo sapiens_hsa04142 | 0.56230985 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55946009 |
115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55601220 |
116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54942889 |
117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54458116 |
118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54187175 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53968659 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53925610 |
121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53602847 |
122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52944368 |
123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52862868 |
124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52784755 |
125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52536956 |
126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52269951 |
127 | Melanogenesis_Homo sapiens_hsa04916 | 0.52024447 |
128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51972487 |
129 | Prostate cancer_Homo sapiens_hsa05215 | 0.51454066 |
130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47521436 |
131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47055261 |
132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46917370 |
133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46577173 |
134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46192019 |
135 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46188251 |
136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45784960 |
137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45738391 |
138 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42540330 |
139 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42366235 |